Monsanto explains why new GMO soybeans were released before dicamba formulation approved

Screen Shot at AM

When serious drift issues began popping up around the Mid-South in late June, dicamba immediately became the prime suspect.

The reason? Monsanto’s Roundup Ready 2 Xtend soybean seed had been approved for planting in 2016. However, the company’s new dicamba formulation with lower volatility had not. In fact, no dicamba product has been approved for use with the Xtend technology.

. . . .

On July 26, Delta Farm Press spoke with Dan Urnikis, Monsanto Industry Affairs Lead, and Kyel Richard, the company’s Product Communications Lead. Among their comments:

. . . .

Why did you put the Xtend out without approval of the new formulations? . . .

. . . .

“So, farmers tell us they’d prefer to try new varieties on their farm . . . to see which work . . . the best. We chose to launch this year to allow growers to experience the . . . Roundup Ready 2 Xtend soybeans. They can plant with confidence this year in anticipation of the chemical approval for the 2017 growing season.”

. . . .

“We have an extensive communication plan – not only to dealers, but to growers, to our technology use guides – ensuring it is clear any over-the-top use of dicamba is illegal. . . . ”

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Read full, original post: Monsanto explains actions as dicamba drift fallout continues

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
Screenshot 2026-05-06 at 2.56
Singularity crisis ahead? Can super babies save us from rogue AI geniuses?
Screenshot-2026-05-06-at-2.07.43-PM
Manufacturing a conspiracy: The timeline of how  the White House embraced the fringe claim that scientists are being mysteriously murdered
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
Screenshot-2026-04-30-at-2.19.37-PM
5 myths about summer dehydration that could damage your health — or even kill you
Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
ChatGPT-Image-May-6-2026-03_41_05-PM
‘Protecting the integrity of science’: Kennedy’s FDA blocks release of taxpayer-funded studies finding COVID and shingles vaccines safe
Screenshot 2026-05-06 at 12.49
Immortal dragons: The quest to ‘make death optional’
Screenshot-2026-05-01-at-11.56.24-AM
‘Science moves forward when people are willing to think differently’: Memories of DNA maverick Craig Venter
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.